Mylan/King Merger Brings Another Twist To Levothyroxine Generics
This article was originally published in The Pink Sheet Daily
Executive Summary
Mylan's launch of a generic version of the thyroid hormone levothyroxine will not be affected by the proposed acquisition of Levoxyl-manufacturer King Pharmaceuticals, Mylan maintained during a July 26 conference call